ENGLEWOOD CLIFFS, N.J., January 8, 2026 – CNBC, First in Business Worldwide, today announced a new multi-platform initiative, CNBC Cures, a groundbreaking resource dedicated to showcasing the voices, research, and progress surrounding rare diseases and bringing awareness to the 30 million Americans suffering from them. Led by CNBC’s “Squawk Box” Co-Anchor Becky Quick, CNBC Cures is designed to be a central hub bringing together families, doctors, investors, and regulators from around the country to support those impacted and help to improve their outcome.

“My connection to CNBC Cures is a personal one – my youngest daughter Kaylie was diagnosed with SYNGAP1, a very rare disease caused by a variant on the SYNGAP1 gene.” said Quick. “My journey with her diagnosis and treatment has been tough and at times lonely but with this initiative, I’m hoping to create a space with a shared mission to recognize, collaborate, and find solutions for those living with rare diseases.”

CNBC Cures will feature exclusive stories and breaking news that highlight cutting-edge research and emerging treatments, key investments fueling innovation in the rare disease space, character-driven accounts from patients and their families, and testimonials from prominent business leaders and investors sharing their work and personal connections to those with rare diseases. In addition to regular coverage, there will also be a videocast and weekly newsletter that spotlight the most important stories of the week.

“Rare diseases impact millions of families, and CNBC is committed to being a trusted voice on the issues that matter most,” said David Cho, Editor-in-Chief of CNBC. “CNBC Cures will bring together leaders from business and medicine to turn insight into action — and offer hope to families navigating these conditions.”

The CNBC editorial team will work with the CNBC Cures Advisory Board, comprised of top medical professionals, business leaders, executives and investors, to provide critical insight and support of this cause.

CNBC Cures Advisory Board members include:

Amy Abernethy, Highlander Health Co-Founder
Madeline Bell, Children’s Hospital of Philadelphia CEO
Wendy Chung, Boston Children’s Hospital Department of Pediatrics Chief
Stanley Crooke, n-Lorem Foundation Chairman & CEO
Alex Gorsky, Johnson & Johnson Former Chairman & CEO
Scott Gottlieb, Former FDA Commissioner
Anna Greka, Mass General Brigham Professor Harvard Medical School
Akshay Jain, Jain Foundation Chairman & CEO
Sunitha Malepati, Buffalo Initiative Founder & CEO
Amy McCooe, The Wolverine Foundation Executive Director
Matthew State, UCSF Child Psychiatrist & Human Geneticist

CNBC Cures will also host an event on March 3 in New York City to drive this important conversation around rare diseases. To sign up or learn more about the event, visit: cnbcevents.com/cures.

About CNBC:

CNBC, First in Business Worldwide, is the recognized global leader in business and financial news. With headquarters in New Jersey, London, and Singapore, CNBC covers financial markets in real-time, offering breaking news, exclusive interviews, stocks and trading analysis, and in-depth reports on factors driving the economy. CNBC’s mission is to help business leaders, the financial community and anyone with assets to invest or protect, make informed money decisions and get ahead.

CNBC’s vast portfolio includes the TV channel, available in over 366 million households, hotels and office buildings across 154 countries; CNBC.com, the online destination for the latest financial news and information; CNBC PRO, the network’s premium subscription service with first access to markets and influential voices, as well as the CNBC app, podcasts, newsletters, live events, and social media and digital video platforms.

CNBC is a VERSANT brand. For more information, visit www.cnbc.com.